• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX 35 DRUG-ELUTING STENT; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX 35 DRUG-ELUTING STENT; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-6-100-PTX
Device Problem Restricted Flow rate (1248)
Patient Problems Amputation (1702); Gangrene (1873)
Event Date 10/24/2014
Event Type  Injury  
Event Description
On the (b)(6) 2014 the pt underwent an aortogram on the right leg and the physician implanted two zilver ptx stents (one 6x 100 and one 6x80).On the (b)(6) 2014 there was no blood flow down the leg and it appeared the stents had shut down not allowing the blood to flow.Due to some gangrene setting in the physician amputated the leg below the knee on the (b)(6) 2014.On the (b)(6) 2014 the pt had covered stents placed inside the zilver ptx stents to allow the blood flow to the distal end of the leg stump.The info received indicated the pt is well.This report relates to the ziv6-35-125-6-100-ptx device.Reference also relates mdr report 3001845648-2014-00312.
 
Manufacturer Narrative
(b)(4).The device involved in this complaint remains implanted in the pt therefore will not be returned to cook ireland for eval.With the info provided a document based investigation was carried out.Angiography images have been requested but images are not available to be provided.As the device has not been received the cause of this complaint could not be conclusively determined.From the info provided, the stent placed was occluded approx 1 month after placement.It is possible that this occlusion could be related to thrombotic occlusion, however as images and additional info are not available to be provided, this cannot be conclusively determined.Thrombosis is a known potential adverse effect as per (b)(4).The below list indicates potential risk factors that can generally contribute to the thrombosis event: pt factors, diabetes, especially if poorly controlled, cancer, smoking,.From the info provided, plavix was not being taken at times per prescribed instructions.The customer complaint could be confirmed based on customer testimony.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the mfg records for zilver ptx and zilver ptx drug eluting stent could not be performed as the lot number was not provided.From the info provided, the pt had covered stent placed inside the zilver stent to get the blood flow to the distal end of the leg stump after the amputation.The pt is doing well.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX 35 DRUG-ELUTING STENT
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
limerick
EI 
Manufacturer Contact
sinead quaid, sr specialist
61334440
MDR Report Key4332200
MDR Text Key5142394
Report Number3001845648-2014-00311
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P100022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician Assistant
Type of Report Initial
Report Date 11/05/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/03/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberZIV6-35-125-6-100-PTX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/24/2014
Event Location Hospital
Date Manufacturer Received11/14/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability;
Patient Age64 YR
Patient Weight106
-
-